Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents

Diabetes Care

Volumn 32, Issue 4, 2009, Pages 695-701

  Huang, Rae Chi ^a   Mori, Trevor A ^a   Burke, Valerie ^a   Newnham, John ^a   Stanley, Fiona J ^b   Landau, Louis I ^a   Kendall, Garth E ^b,c   Oddy, Wendy H ^b   Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADOLESCENT; ALANINE TRANSAMINASE; AUSTRALIA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CLUSTER ANALYSIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC DISEASES; OVERWEIGHT; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; URIC ACID;

EID: 65349109733     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1917     Document Type: Article

References (25)

1. Wang Y, Beydoun MA: The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6-28, 2007
2. Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878-881, 2005
3. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380-385, 2004
4. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 21:52-58, 2004
5. Patel DA, Srinivasan SR, XuJH, Chen W, Berenson GS: Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism56:792-798, 2007
6. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H: 7-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130-2137, 2005
7. Andre P, Balkau B, Born C, Charles MA, Eschwege E: Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49:2599-2603, 2006
8. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study. JAMA 283:2404-2410, 2000
9. Greenfield JR, Campbell LV: Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2:195-211, 2006
10. HuangRC, BurkeV, NewnhamJP, StanleyFJ, Kendall GE, Landau LI, Oddy WH, Blake KV, Palmer LJ, Beilin LJ: Perinatal and childhood origins of cardiovascular disease. Int J Obes (Lond) 31:236-244, 2007
11. Warnick GR, Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76, 1978
12. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low- density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and (β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
15. Zhang TRR, Livny M: BIRCH: An efficient data clustering method for very large databases. In Proceedings of the ACM SIGMOD Conference on Management of Data, Montreal, QC, Canada. New York, ACM Press, 1996, p. 103-114
16. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
17. Cook S, Auinger P, Li C, Ford ES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 152:165-170, 2008
18. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S: The metabolic syndrome in children and adolescents. Lancet 369:2059-2061, 2007
19. Goodman E, Daniels SR, Meigs JB, Dolan LM: Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 115:2316 -2322, 2007
20. Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS: Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 55:699-705, 2006
21. de Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N: Inflammation and changes in metabolic syndrome abnormalities in US Adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 52:1325-1330, 2006
22. Bugianesi E, McCullough AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42:987-1000, 2005
23. Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL: Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45:34-38, 2005
24. Desai MY, Santos RD, Dalal D, Carvalho JA, Martin DR, Flynn JA, Nasir K, Blumenthal RS: Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am J Cardiol 95:865-868, 2005
25. Birjmohun RS, vanLeuven SI, Levels JH, van't Veer C, Kuivenhoven JA, Meijers JC, Levi M, Kastelein JJ, van der Poll T, Stroes ES: High- density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 27:1153-1158, 2007